Insights of Chinese herbal medicine for mitochondrial dysfunction in chronic cerebral hypoperfusion induced cognitive impairment: Existed evidences and potential directions

被引:5
作者
Wang, Yefei [1 ]
Wang, Ying [1 ]
Li, Shixin [1 ]
Jin, Huihui [1 ]
Duan, Jiayu [1 ]
Lu, Xiyue [1 ]
Qin, Yinglin [1 ]
Song, Jiale [1 ]
Li, Xiaoshan [1 ]
Jin, Xianglan [2 ]
机构
[1] Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Dongfang Hosp, Dept Neurol, Beijing, Peoples R China
关键词
chronic cerebral hypoperfusion; cognitive impairment; mitochondria; mitochondrial dysfunction; Chinese herbal medicine; OXIDATIVE STRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CELL-DEATH; RAT; DEMENTIA; BRAIN; MECHANISMS; EDARAVONE; PATHOLOGY;
D O I
10.3389/fphar.2023.1138566
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic cerebral hypoperfusion (CCH) is one of the main pathophysiological markers of cognitive impairment in central nervous system diseases. Mitochondria are cores of energy generation and information process. Mitochondrial dysfunction is the key upstream factors of CCH induced neurovascular pathology. Increasing studies explored the molecular mechanisms of mitochondrial dysfunction and self-repair for effective targets to improve CCH-related cognitive impairment. The clinical efficacy of Chinese herbal medicine in the treatment of CCH induced cognitive impairment is definite. Existed evidences from pharmacological studies have further proved that, Chinese herbal medicine could improve mitochondrial dysfunction and neurovascular pathology after CCH by preventing calcium overload, reducing oxidative stress damage, enhancing antioxidant capacity, inhibiting mitochondria-related apoptosis pathway, promoting mitochondrial biogenesis and preventing excessive activation of mitophagy. Besides, CCH mediated mitochondrial dysfunction is one of the fundamental causes for neurodegeneration pathology aggravation. Chinese herbal medicine also has great potential therapeutic value in combating neurodegenerative diseases by targeting mitochondrial dysfunction.
引用
收藏
页数:15
相关论文
共 89 条
[71]  
Wu Q., 2017, WORLD CHIN MED, V12, P2403
[72]  
Yan Y. M., 2022, MILITARY MED RES, V38, P159, DOI [10.13412/j.cnki.zyyl.20220317.001, DOI 10.13412/J.CNKI.ZYYL.20220317.001]
[73]   Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damage [J].
Yang, Shilun ;
Wang, Haigang ;
Yang, Yinglin ;
Wang, Rui ;
Wang, Yuehua ;
Wu, Chunfu ;
Du, Guanhua .
BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
[74]  
Yang Y. R., 2022, WORLD J PEDIATR, V40, P39
[75]  
Yang Z, 2013, NEW ENGL J MED, V369, P489, DOI 10.1056/NEJMc1305541
[76]  
Yu M., 2014, J NEUROL NEUROREHAB, V11, P52
[77]   A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis [J].
Yu, Weiwei ;
Li, Yao ;
Hu, Jun ;
Wu, Jun ;
Huang, Yining .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
[78]   Mitochondrial dynamics proteins as emerging drug targets [J].
Zacharioudakis, Emmanouil ;
Gavathiotis, Evripidis .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (02) :112-127
[79]   Degradation Products of Amyloid Protein: Are They the Culprits? [J].
Zaretsky, Dmitry, V ;
Zaretskaia, Maria .
CURRENT ALZHEIMER RESEARCH, 2020, 17 (10) :869-880
[80]   Targeting Akt/CREB/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach [J].
Zarneshan, Seyede Nazanin ;
Fakhri, Sajad ;
Khan, Haroon .
PHARMACOLOGICAL RESEARCH, 2022, 177